DEFA14A: Kindly MD Sets 2025 Annual Meeting, Key Votes Ahead
Proxy Statement
Kindly MD, Inc. announces its 2025 Annual Meeting of Stockholders to be held virtually on December 17, 2025, to vote on director elections, corporate reincorporation, auditor ratification, and meeting adjournment.
Summary
- Kindly MD, Inc. will hold its 2025 Annual Meeting of Stockholders virtually on December 17, 2025, at 8:30 a.m. Mountain Time.
- Stockholders are requested to vote on four key proposals.
- Proposal 1 involves the election of two Class I director nominees to the Board of Directors.
- Proposal 2 seeks approval for the conversion of Kindly MD, Inc. from a Utah corporation to a Delaware corporation.
- Proposal 3 is for the ratification of Sadler, Gibb & Associates, LLC as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
- Proposal 4 requests approval for the adjournment of the 2025 Annual Meeting if necessary to permit further solicitation and voting of proxies or to establish a quorum.
- The Board of Directors recommends voting FOR all director nominees in Proposal 1, and FOR Proposals 2, 3, and 4.
Sentiment
Score: 6
Explanation: The filing is a routine proxy statement outlining standard corporate governance procedures for an upcoming annual meeting, including director elections, auditor ratification, and a proposed reincorporation, which are generally positive indicators of ongoing operations and compliance.
Positives
- The company is adhering to standard corporate governance practices by holding an annual meeting and seeking stockholder approval for key corporate actions.
- Proposing reincorporation to Delaware, a jurisdiction often favored by corporations for its well-developed and predictable corporate law.
- Ratification of an independent auditor ensures ongoing financial oversight and compliance with regulatory requirements.
Risks
- There is a risk of insufficient votes in favor of proposals 1-3, which could necessitate the adjournment of the 2025 Annual Meeting.
- There is a risk of not having sufficient shares present to establish a quorum at the meeting, potentially leading to an adjournment.
Future Outlook
The company plans to elect directors, seek approval for reincorporation from Utah to Delaware, and ratify its independent auditor for the fiscal year ending December 31, 2025. The potential for meeting adjournment indicates a contingency plan for ensuring all proposals receive adequate consideration and votes.
Management Comments
- The Board of Directors recommends that you vote your shares FOR ALL the director nominees in Proposal 1, and FOR Proposals 2, 3, and 4.
Industry Context
Annual meetings and proxy solicitations are fundamental corporate governance practices for publicly traded companies, ensuring transparency and providing stockholders with the opportunity to participate in key decisions. The proposed reincorporation to Delaware is a common strategic move for companies seeking a well-established and predictable legal framework for corporate law, often seen as an industry standard.
Comparison to Industry Standards
- Holding an annual meeting and soliciting proxies for director elections and auditor ratification aligns with standard corporate governance practices for publicly traded companies in the U.S.
- The proposal to reincorporate to Delaware is a common strategic decision, as Delaware's comprehensive and predictable corporate legal system is widely considered an industry standard for public companies, offering advantages in corporate governance and legal certainty.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Proposed Reincorporation | Conversion of Kindly MD, Inc. from a Utah corporation to a Delaware corporation, pending stockholder approval. | Not specified, pending stockholder approval | Delaware is generally favored for its well-developed and predictable corporate law, which can offer advantages in corporate governance and legal certainty. |
| Auditor Ratification | Ratification of Sadler, Gibb & Associates, LLC as the independent registered public accounting firm for the fiscal year ending December 31, 2025. | For the fiscal year ending December 31, 2025 | Ensures independent oversight of financial reporting and compliance with regulatory requirements. |
Stakeholder Impact
- Shareholders: Will have the opportunity to vote on key corporate governance matters, including director elections and a significant corporate structure change (reincorporation), directly influencing the company's future direction and oversight.
- Management/Board: The outcome of director elections will determine the composition of the board, and the reincorporation will affect the legal framework under which they operate.
- Auditors: Sadler, Gibb & Associates, LLC will continue their role, ensuring financial oversight if ratified.
Next Steps
- Stockholders are to vote on the proposed election of two Class I director nominees at the 2025 Annual Meeting.
- Stockholders are to vote on the proposed conversion of Kindly MD, Inc. from a Utah to a Delaware corporation.
- Stockholders are to vote on the proposed ratification of Sadler, Gibb & Associates, LLC as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
- The 2025 Annual Meeting may be adjourned to a later date if there are insufficient votes for proposals or to establish a quorum.
Key Dates
| Date | Description |
|---|---|
| December 3, 2025 | Deadline to request a paper or e-mail copy of the proxy materials. |
| December 17, 2025 | Date of the 2025 Annual Meeting of Stockholders, held virtually at 8:30 a.m. Mountain Time. |
| December 31, 2024 | Fiscal year end for the Annual Report on Form 10-K, which is available for review. |
| December 31, 2025 | Fiscal year end for which Sadler, Gibb & Associates, LLC is proposed to be ratified as the independent registered public accounting firm. |
Keywords
Proxy Statement, Annual Meeting, Kindly MD, Corporate Governance, Director Election, Reincorporation, Delaware, Utah, Auditor Ratification, Stockholder Vote, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.